Johnson & Johnson's one-shot Covid vaccine effective, FDA review says

Advisory panel will meet on Friday to decide whether to recommend the vaccine be authorized

Johnson & Johnson's one-shot coronavirus vaccine appeared safe and effective in trials, US Food and Drug Administration (FDA) staff said in documents published on Wednesday, paving the way for emergency authorization in the US.

An advisory panel of independent experts will meet on Friday to decide whether to recommend the vaccine be authorized. While the FDA is not bound to follow the advice of its experts, the agency did so when authorizing the Pfizer and Moderna vaccines late last year.